These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 15949853)

  • 1. Baroreflex sensitivity normalization after cardiac resynchronization therapy.
    Sarzi Braga S; La Rovere MT; Pedretti RF
    Int J Cardiol; 2006 Apr; 109(1):118-20. PubMed ID: 15949853
    [No Abstract]   [Full Text] [Related]  

  • 2. Estimated prevalence of implanted electrophysiologic devices in patients with heart failure.
    Mills RM; Zhu V; Cody RJ; Yuan Z
    Am Heart J; 2015 Jan; 169(1):188-9. PubMed ID: 25497266
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: "Effects of cardiac resynchronization therapy on heart rate turbulence".
    Gademan MG; Swenne CA
    Pacing Clin Electrophysiol; 2009 Jul; 32(7):964; author reply 964-5. PubMed ID: 19572883
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term outcome in diabetic heart failure patients treated with cardiac resynchronization therapy.
    Fantoni C; Regoli F; Ghanem A; Raffa S; Klersy C; Sorgente A; Faletra F; Baravelli M; Inglese L; Salerno-Uriarte JA; Klein HU; Moccetti T; Auricchio A
    Eur J Heart Fail; 2008 Mar; 10(3):298-307. PubMed ID: 18296111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. When is it too late for cardiac resynchronization therapy?
    Herweg B; Barold SS
    Pacing Clin Electrophysiol; 2008 May; 31(5):525-8. PubMed ID: 18439163
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of cardiac resynchronization therapy on heart rate turbulence.
    Sredniawa B; Lenarczyk R; Musialik-Lydka A; Kowalski O; Kowalczyk J; Cebula S; Sliwinska A; Szulik M; Kalarus Z
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S90-3. PubMed ID: 19250121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Measurements of heart rate variability and baroreflex sensitivity].
    Sevre K; Rostrup M
    Tidsskr Nor Laegeforen; 2001 Oct; 121(26):3059-64. PubMed ID: 11757441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of N-type Ca2+ channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure.
    Yamada Y; Kinoshita H; Kuwahara K; Nakagawa Y; Kuwabara Y; Minami T; Yamada C; Shibata J; Nakao K; Cho K; Arai Y; Yasuno S; Nishikimi T; Ueshima K; Kamakura S; Nishida M; Kiyonaka S; Mori Y; Kimura T; Kangawa K; Nakao K
    Cardiovasc Res; 2014 Oct; 104(1):183-93. PubMed ID: 25100767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using echocardiography in cardiac resynchronization therapy.
    Mullens W; Tang WH; Grimm RA
    Am Heart J; 2007 Dec; 154(6):1011-20. PubMed ID: 18035069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac resynchronization therapy using a VDD lead.
    D'Ivernois C; Pi S; Hero M
    Pacing Clin Electrophysiol; 2005 Nov; 28(11):1240-2. PubMed ID: 16359296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pacemaker implantation as a risk factor for heart failure in young adults with congenital heart disease.
    Nothroff J; Norozi K; Alpers V; Arnhold JO; Wessel A; Ruschewski W; Buchhorn R
    Pacing Clin Electrophysiol; 2006 Apr; 29(4):386-92. PubMed ID: 16650267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of cardiac resynchronisation therapy in patients with echocardiographic evidence of mechanical dyssynchrony.
    Achilli A; Sassara M; Pontillo D; Turreni F; Rossi P; De Luca R; Klersy C; Patruno N; Achilli P; Sallusti L; Spadaccia P; Cricco L; Serra F
    J Cardiovasc Med (Hagerstown); 2008 Feb; 9(2):131-6. PubMed ID: 18192804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Responders to cardiac resynchronization therapy with narrow or intermediate QRS complexes identified by simple echocardiographic indices of dyssynchrony: the DESIRE study.
    Cazeau SJ; Daubert JC; Tavazzi L; Frohlig G; Paul V
    Eur J Heart Fail; 2008 Mar; 10(3):273-80. PubMed ID: 18314381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRT-D therapy in heart failure: how much do NYHA class IV patients benefit?
    Lehmann MH; Aaronson KD
    J Cardiovasc Electrophysiol; 2006 May; 17(5):491-4. PubMed ID: 16684020
    [No Abstract]   [Full Text] [Related]  

  • 15. Echocardiography in cardiac resynchronization therapy.
    Naqvi TZ; Rafique AM
    Minerva Cardioangiol; 2005 Apr; 53(2):93-108. PubMed ID: 15986004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced heart failure: Where do we stand?
    Tousoulis D
    Hellenic J Cardiol; 2018; 59(6):303-305. PubMed ID: 30853606
    [No Abstract]   [Full Text] [Related]  

  • 17. [Autonomic nervous system examinations].
    Watanabe E; Kodama I
    Nihon Rinsho; 2002 Jul; 60(7):1299-307. PubMed ID: 12136607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autonomic alterations and cardiac changes in epilepsy.
    Sevcencu C; Struijk JJ
    Epilepsia; 2010 May; 51(5):725-37. PubMed ID: 20067509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart rate turbulence.
    Cygankiewicz I
    Prog Cardiovasc Dis; 2013; 56(2):160-71. PubMed ID: 24215748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autonomic nervous system in the genesis of arrhythmias in chronic heart failure: implication for risk stratification.
    Piepoli MF; Capucci A
    Minerva Cardioangiol; 2007 Jun; 55(3):325-33. PubMed ID: 17534251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.